A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma
Status:
Terminated
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine the Maximum Tolerated Dose (MTD) and efficacy of
the combined treatment of Temsirolimus and Sunitinib for the treatment of Advanced Kidney
Cancer